Safety Considerations with Niacin Therapy
- 19 March 2007
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 99 (6), S22-S31
- https://doi.org/10.1016/j.amjcard.2006.11.018
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatmentInternational Journal of Clinical Practice, 2006
- Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemiaThe American Journal of Cardiology, 2000
- Extended-Release Niacin vs Gemfibrozil for the Treatment of Low Levels of High-Density Lipoprotein CholesterolArchives of Internal Medicine, 2000
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemiaMetabolism, 1998
- Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients with Hypercholesterolemia: A Placebo-controlled TrialJournal of Cardiovascular Pharmacology and Therapeutics, 1996
- The prevalence of side effects with regular and sustained-release nicotinic acidAmerican Journal Of Medicine, 1995
- Identification of Skin as a Major Site on Prostaglandin D2 Release Following Oral Administration of Niacin in HumansJournal of Investigative Dermatology, 1992
- Tolerance to nicotinic acid flushingClinical Pharmacology & Therapeutics, 1991
- Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacinMetabolism, 1985
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975